Lymphadenectomy and Ovarian Preservation in Low-Grade Endometrial Stromal Sarcoma

To report the impact on overall survival of lymphadenectomy and ovarian preservation in patients with endometrial stromal sarcoma. Data were extracted from the Surveillance, Epidemiology, and End Results Program from 1988 to 2005. Kaplan-Meier and Cox proportional hazards analyses were used to ident...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Obstetrics and gynecology (New York. 1953) 2008-11, Vol.112 (5), p.1102-1108
Hauptverfasser: Shah, Jay P., Bryant, Christopher S., Kumar, Sanjeev, Ali-Fehmi, Rouba, Malone, John M., Morris, Robert T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1108
container_issue 5
container_start_page 1102
container_title Obstetrics and gynecology (New York. 1953)
container_volume 112
creator Shah, Jay P.
Bryant, Christopher S.
Kumar, Sanjeev
Ali-Fehmi, Rouba
Malone, John M.
Morris, Robert T.
description To report the impact on overall survival of lymphadenectomy and ovarian preservation in patients with endometrial stromal sarcoma. Data were extracted from the Surveillance, Epidemiology, and End Results Program from 1988 to 2005. Kaplan-Meier and Cox proportional hazards analyses were used to identify possible predictors for survival. Nine hundred seventy women were reported with endometrial stromal sarcoma. The 384 women with low-grade endometrial stromal sarcoma had a younger age, earlier stage, and longer survival than the 320 women with high-grade lesions. Among the low-grade endometrial stromal sarcoma patients, the incidence of extrauterine disease was 25%, and lymph node metastasis was 7%. Univariable and multivariable analysis demonstrated lymph node metastasis and ovarian preservation were not significant prognostic factors for survival. In low-grade endometrial stromal sarcoma, the risk of extrauterine spread and lymph node metastasis merit consideration for surgical staging. Neither lymph node metastasis nor ovarian preservation seems to affect the excellent overall survival of these patients. II.
doi_str_mv 10.1097/AOG.0b013e31818aa89a
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69743367</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69743367</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4260-ce9a6c07c0ab1a2d007401841570ccfc371eeb696ad3b4f2922d02c0d39549da3</originalsourceid><addsrcrecordid>eNpdkU9r20AQxZeS0rhJv0EouiQ3JbN_rN09hpC4BYNTkkBvy2g1wkolrbsrx_jbZ0NMW3oY3gz85g28YeyMwyUHq6-uV4tLqIFLktxwg2gsfmAzbrQshZQ_j9gMQNhSG6WO2eeUngGAV1Z-YsfcWG04FzP2Y7kfNmtsaCQ_hWFf4NgUqxeMHY7FfaRE8QWnLoxFNxbLsCsXMcPF7diEgaZM9cXDFMPwphh9bk7Zxxb7RF8OesKe7m4fb76Vy9Xi-831svRKVFB6slh50B6w5igaAK2AG8XnGrxvvdScqK5shY2sVSusyIzw0Eg7V7ZBecIu3n03MfzeUprc0CVPfY8jhW1yldVKykpnUL2DPoaUIrVuE7sB495xcG9Ruhyl-z_KvPb14L-tB2r-Lh2yy8D5AcDksW8jjr5LfzgBRszB_HN_F_qJYvrVb3cU3Zqwn9YuPwWqDJYCINvmqcwlQL4CdP2NSA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69743367</pqid></control><display><type>article</type><title>Lymphadenectomy and Ovarian Preservation in Low-Grade Endometrial Stromal Sarcoma</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Shah, Jay P. ; Bryant, Christopher S. ; Kumar, Sanjeev ; Ali-Fehmi, Rouba ; Malone, John M. ; Morris, Robert T.</creator><creatorcontrib>Shah, Jay P. ; Bryant, Christopher S. ; Kumar, Sanjeev ; Ali-Fehmi, Rouba ; Malone, John M. ; Morris, Robert T.</creatorcontrib><description>To report the impact on overall survival of lymphadenectomy and ovarian preservation in patients with endometrial stromal sarcoma. Data were extracted from the Surveillance, Epidemiology, and End Results Program from 1988 to 2005. Kaplan-Meier and Cox proportional hazards analyses were used to identify possible predictors for survival. Nine hundred seventy women were reported with endometrial stromal sarcoma. The 384 women with low-grade endometrial stromal sarcoma had a younger age, earlier stage, and longer survival than the 320 women with high-grade lesions. Among the low-grade endometrial stromal sarcoma patients, the incidence of extrauterine disease was 25%, and lymph node metastasis was 7%. Univariable and multivariable analysis demonstrated lymph node metastasis and ovarian preservation were not significant prognostic factors for survival. In low-grade endometrial stromal sarcoma, the risk of extrauterine spread and lymph node metastasis merit consideration for surgical staging. Neither lymph node metastasis nor ovarian preservation seems to affect the excellent overall survival of these patients. II.</description><identifier>ISSN: 0029-7844</identifier><identifier>EISSN: 1873-233X</identifier><identifier>DOI: 10.1097/AOG.0b013e31818aa89a</identifier><identifier>PMID: 18978112</identifier><identifier>CODEN: OBGNAS</identifier><language>eng</language><publisher>New York, NY: The American College of Obstetricians and Gynecologists</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Endometrial Neoplasms - pathology ; Endometrial Neoplasms - surgery ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Kaplan-Meier Estimate ; Lymph Node Excision ; Lymphatic Metastasis ; Medical sciences ; Middle Aged ; Retrospective Studies ; Sarcoma, Endometrial Stromal - pathology ; Sarcoma, Endometrial Stromal - surgery ; SEER Program ; Sentinel Lymph Node Biopsy ; Young Adult</subject><ispartof>Obstetrics and gynecology (New York. 1953), 2008-11, Vol.112 (5), p.1102-1108</ispartof><rights>The American College of Obstetricians and Gynecologists</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4260-ce9a6c07c0ab1a2d007401841570ccfc371eeb696ad3b4f2922d02c0d39549da3</citedby><cites>FETCH-LOGICAL-c4260-ce9a6c07c0ab1a2d007401841570ccfc371eeb696ad3b4f2922d02c0d39549da3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20825087$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18978112$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shah, Jay P.</creatorcontrib><creatorcontrib>Bryant, Christopher S.</creatorcontrib><creatorcontrib>Kumar, Sanjeev</creatorcontrib><creatorcontrib>Ali-Fehmi, Rouba</creatorcontrib><creatorcontrib>Malone, John M.</creatorcontrib><creatorcontrib>Morris, Robert T.</creatorcontrib><title>Lymphadenectomy and Ovarian Preservation in Low-Grade Endometrial Stromal Sarcoma</title><title>Obstetrics and gynecology (New York. 1953)</title><addtitle>Obstet Gynecol</addtitle><description>To report the impact on overall survival of lymphadenectomy and ovarian preservation in patients with endometrial stromal sarcoma. Data were extracted from the Surveillance, Epidemiology, and End Results Program from 1988 to 2005. Kaplan-Meier and Cox proportional hazards analyses were used to identify possible predictors for survival. Nine hundred seventy women were reported with endometrial stromal sarcoma. The 384 women with low-grade endometrial stromal sarcoma had a younger age, earlier stage, and longer survival than the 320 women with high-grade lesions. Among the low-grade endometrial stromal sarcoma patients, the incidence of extrauterine disease was 25%, and lymph node metastasis was 7%. Univariable and multivariable analysis demonstrated lymph node metastasis and ovarian preservation were not significant prognostic factors for survival. In low-grade endometrial stromal sarcoma, the risk of extrauterine spread and lymph node metastasis merit consideration for surgical staging. Neither lymph node metastasis nor ovarian preservation seems to affect the excellent overall survival of these patients. II.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Endometrial Neoplasms - pathology</subject><subject>Endometrial Neoplasms - surgery</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Lymph Node Excision</subject><subject>Lymphatic Metastasis</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><subject>Sarcoma, Endometrial Stromal - pathology</subject><subject>Sarcoma, Endometrial Stromal - surgery</subject><subject>SEER Program</subject><subject>Sentinel Lymph Node Biopsy</subject><subject>Young Adult</subject><issn>0029-7844</issn><issn>1873-233X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU9r20AQxZeS0rhJv0EouiQ3JbN_rN09hpC4BYNTkkBvy2g1wkolrbsrx_jbZ0NMW3oY3gz85g28YeyMwyUHq6-uV4tLqIFLktxwg2gsfmAzbrQshZQ_j9gMQNhSG6WO2eeUngGAV1Z-YsfcWG04FzP2Y7kfNmtsaCQ_hWFf4NgUqxeMHY7FfaRE8QWnLoxFNxbLsCsXMcPF7diEgaZM9cXDFMPwphh9bk7Zxxb7RF8OesKe7m4fb76Vy9Xi-831svRKVFB6slh50B6w5igaAK2AG8XnGrxvvdScqK5shY2sVSusyIzw0Eg7V7ZBecIu3n03MfzeUprc0CVPfY8jhW1yldVKykpnUL2DPoaUIrVuE7sB495xcG9Ruhyl-z_KvPb14L-tB2r-Lh2yy8D5AcDksW8jjr5LfzgBRszB_HN_F_qJYvrVb3cU3Zqwn9YuPwWqDJYCINvmqcwlQL4CdP2NSA</recordid><startdate>20081101</startdate><enddate>20081101</enddate><creator>Shah, Jay P.</creator><creator>Bryant, Christopher S.</creator><creator>Kumar, Sanjeev</creator><creator>Ali-Fehmi, Rouba</creator><creator>Malone, John M.</creator><creator>Morris, Robert T.</creator><general>The American College of Obstetricians and Gynecologists</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20081101</creationdate><title>Lymphadenectomy and Ovarian Preservation in Low-Grade Endometrial Stromal Sarcoma</title><author>Shah, Jay P. ; Bryant, Christopher S. ; Kumar, Sanjeev ; Ali-Fehmi, Rouba ; Malone, John M. ; Morris, Robert T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4260-ce9a6c07c0ab1a2d007401841570ccfc371eeb696ad3b4f2922d02c0d39549da3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Endometrial Neoplasms - pathology</topic><topic>Endometrial Neoplasms - surgery</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Lymph Node Excision</topic><topic>Lymphatic Metastasis</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><topic>Sarcoma, Endometrial Stromal - pathology</topic><topic>Sarcoma, Endometrial Stromal - surgery</topic><topic>SEER Program</topic><topic>Sentinel Lymph Node Biopsy</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shah, Jay P.</creatorcontrib><creatorcontrib>Bryant, Christopher S.</creatorcontrib><creatorcontrib>Kumar, Sanjeev</creatorcontrib><creatorcontrib>Ali-Fehmi, Rouba</creatorcontrib><creatorcontrib>Malone, John M.</creatorcontrib><creatorcontrib>Morris, Robert T.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Obstetrics and gynecology (New York. 1953)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shah, Jay P.</au><au>Bryant, Christopher S.</au><au>Kumar, Sanjeev</au><au>Ali-Fehmi, Rouba</au><au>Malone, John M.</au><au>Morris, Robert T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lymphadenectomy and Ovarian Preservation in Low-Grade Endometrial Stromal Sarcoma</atitle><jtitle>Obstetrics and gynecology (New York. 1953)</jtitle><addtitle>Obstet Gynecol</addtitle><date>2008-11-01</date><risdate>2008</risdate><volume>112</volume><issue>5</issue><spage>1102</spage><epage>1108</epage><pages>1102-1108</pages><issn>0029-7844</issn><eissn>1873-233X</eissn><coden>OBGNAS</coden><abstract>To report the impact on overall survival of lymphadenectomy and ovarian preservation in patients with endometrial stromal sarcoma. Data were extracted from the Surveillance, Epidemiology, and End Results Program from 1988 to 2005. Kaplan-Meier and Cox proportional hazards analyses were used to identify possible predictors for survival. Nine hundred seventy women were reported with endometrial stromal sarcoma. The 384 women with low-grade endometrial stromal sarcoma had a younger age, earlier stage, and longer survival than the 320 women with high-grade lesions. Among the low-grade endometrial stromal sarcoma patients, the incidence of extrauterine disease was 25%, and lymph node metastasis was 7%. Univariable and multivariable analysis demonstrated lymph node metastasis and ovarian preservation were not significant prognostic factors for survival. In low-grade endometrial stromal sarcoma, the risk of extrauterine spread and lymph node metastasis merit consideration for surgical staging. Neither lymph node metastasis nor ovarian preservation seems to affect the excellent overall survival of these patients. II.</abstract><cop>New York, NY</cop><pub>The American College of Obstetricians and Gynecologists</pub><pmid>18978112</pmid><doi>10.1097/AOG.0b013e31818aa89a</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0029-7844
ispartof Obstetrics and gynecology (New York. 1953), 2008-11, Vol.112 (5), p.1102-1108
issn 0029-7844
1873-233X
language eng
recordid cdi_proquest_miscellaneous_69743367
source MEDLINE; Journals@Ovid Complete
subjects Adolescent
Adult
Aged
Aged, 80 and over
Biological and medical sciences
Endometrial Neoplasms - pathology
Endometrial Neoplasms - surgery
Female
Gynecology. Andrology. Obstetrics
Humans
Kaplan-Meier Estimate
Lymph Node Excision
Lymphatic Metastasis
Medical sciences
Middle Aged
Retrospective Studies
Sarcoma, Endometrial Stromal - pathology
Sarcoma, Endometrial Stromal - surgery
SEER Program
Sentinel Lymph Node Biopsy
Young Adult
title Lymphadenectomy and Ovarian Preservation in Low-Grade Endometrial Stromal Sarcoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T00%3A08%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lymphadenectomy%20and%20Ovarian%20Preservation%20in%20Low-Grade%20Endometrial%20Stromal%20Sarcoma&rft.jtitle=Obstetrics%20and%20gynecology%20(New%20York.%201953)&rft.au=Shah,%20Jay%20P.&rft.date=2008-11-01&rft.volume=112&rft.issue=5&rft.spage=1102&rft.epage=1108&rft.pages=1102-1108&rft.issn=0029-7844&rft.eissn=1873-233X&rft.coden=OBGNAS&rft_id=info:doi/10.1097/AOG.0b013e31818aa89a&rft_dat=%3Cproquest_cross%3E69743367%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69743367&rft_id=info:pmid/18978112&rfr_iscdi=true